Jean-Gabriel Griboul

Partner

Paris + 33.1.56.59.38.92

Conectar

Compartilhe

Jean-Gabriel Griboul has 20 years of experience advising clients on private and public M&A, PE (private equity), and ECM (equity capital market) transactions, including domestic and cross-border acquisitions or investments, divestitures and strategic alliances, and corporate law issues.

He is recognized in numerous legal publications, including Chambers Europe that notes "his commercial sense is valued by clients, one dubbing him ‘efficient, precise and pragmatic’."

Jean-Gabriel has acted as principal lawyer in a significant number of early to late-stage financing rounds, M&A transactions, LBOs (leveraged buyouts), IPOs (initial public offerings), rights issues, tender offers, and private placements.

Recent transactions in which Jean-Gabriel has acted as lead lawyer include:

M&A: sale of Efficient IP to Francisco Partners; build-up acquisitions completed by Doctolib; acquisition by Taranis Investments (Perenco Group) of the African project portfolio of Akuo Energy Afrique; acquisition by DBG Technology of All Circuits; joint venture between EDF Invest and Savills Investment Management; acquisition of Bimpli (BPCE) by Swile; sale of Preligens to Safran; sale of Gleamer to RadNet; and sale of Linkfluence to Meltwater.

Private Equity: LBO of Illuin Technology; MBO (management buyout) of Adikteev; Sanofi's investment in a biotech entity controlled by Orano Med; all financing rounds completed by Swile; Unseenlabs Series C financing round; and ADEME Investissement on the offshore floating wind development company created with BW Ideol.

Capital Markets: Nasdaq IPO of Nanobiotix and ChapsVision tender offer on Coheris.

Experiência

  • EfficientIP sells company to Francisco PartnersJones Day advised Efficient IP and its shareholders (including Jolt Capital and Tempocap), a global leader in DNS, DHCP and IP Address Management (DDI) and DNS security solutions, in the sale of the company to Francisco Partners.
  • Doctolib acquires Medicus HealthJones Day advised Doctolib, a leading digital health unicorn, on its acquisition of Medicus Health, a London-based innovator behind the first new GP clinical software system introduced into the NHS in over 25 years.
  • EDF Invest acquires 50% of Euro Living and enters into joint venture with Savills Investment ManagementJones Day advised EDF Invest, the investment arm of global electricity leader Électricité de France (EDF SA), a global leader in low-carbon electricity generation and supply, on its acquisition of a 50% interest in Euro Living, the holding company of Savills Investment Management’s European Living Fund (EULIV).
  • DBG Technology acquires All Circuits S.A.S. for CNY 730 millionJones Day advised DBG Technology Co., Ltd. in the CNY 730 million acquisition of All Circuits S.A.S. from IEE S.A. and Hiwinglux S.A. (both pertaining to Aerospace Hi-Tech Holding Group Co. Ltd., a China-based public conglomerate).
  • Taranis Investment Limited, a Perenco group company, acquires Africa business of the Akuo GroupJones Day advised Taranis Investment Limited, a Perenco group company, in the acquisition of the African project portfolio from Akuo Energy Afrique, a renewable energy developer.
  • ILLUIN Technology sells majority stake to Seven2Jones Day advised ILLUIN Technology, a software and consulting firm delivering bespoke artificial intelligence solutions for large corporations, in connection with the sale of a majority stake to Seven2.
  • Adikteev bought out by managementJones Day advised Adikteev SA in the management buyout by Xavier Mariani and Emilien Eychenne as well as several other executives.
  • Hedosophia participates in €175 million financing of PennylaneJones Day advised Hedosophia in connection with the €175 million financing of Pennylane, a French based company that develops and operates an all-in-one financial management software to be licensed to accountants and their clients.
  • Ankaa Ventures leads Sepia Infrastructure first fundraisingJones Day advised Ankaa Ventures as a lead investor in the first fundraising for Sepia Infrastructure, a data center land and power provider that develops low-carbon energy solutions for the European industrial technology market.
  • Doctolib acquires Aaron.aiJones Day advised Doctolib, the leading healthtech company in Europe, in its acquisition of the Berlin company Aaron.ai, the current market leader in Germany for AI-based telephone assistance solutions for medical practices, relieving doctors and practice staff of answering telephone calls and offering patients telephone access to doctors' practices around the clock.
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Tikehau Capital, Wendel Growth, Definvest (Bpifrance), and 360 Capital sell their stakes in Preligens to SafranJones Day advised Tikehau Capital, Wendel Growth, Definvest (Bpifrance), and 360 Capital in the sale of their stakes in Preligens, a world leader in artificial intelligence (AI) for aerospace and defense, to Safran.
  • Euroclear invests in IZNESJones Day advised Euroclear in its investment in IZNES, a pan-European funds marketplace based on blockchain technology.
  • Unseenlabs raises €85 millionJones Day advised Unseenlabs, a France-based company and global leader in maritime surveillance through detection and geolocation of radio frequency signals from space, in its €85 million financing for significant expansion of observation capabilities, strengthening of international presence, consolidation of private sector activities, innovation of new products and solutions, and recruitment of new talents.
  • Quandela raises €50 millionJones Day advised Quandela, the European leader in photonic quantum computing, in raising €50 million from investors, the French government through the France 2030 Plan, and banking partners, allowing Quandela to expedite its international expansion and increase the production of its quantum computers to meet the needs of industrial clients.
  • Swile raises $200 million in Series D financingJones Day advised Swile, a French-based tech company that offers digital solutions for employee rewards and benefits through a custom card and app, in connection with its $200 million Series D round of financing led by SoftBank, alongside existing investors Index Ventures, Eurazeo and Bpifrance Large Venture.
  • Société Generale, Demeter and ADEME participate in €35 million financing round of Qarnot ComputingJones Day advised Société Generale Ventures, Demeter and ADEME in connection with their participation in the €35 million financing round of Qarnot Computing, a French start-up using data centers and computers as heat source.
  • Portage and Orange Ventures lead €37 million Series C financing of MooncardJones Day advised Portage and Orange Ventures as lead investors in connection with the €37 million Series C financing of Mooncard, the French leader in the automation of corporate spend, in which historical investors Aglaé Ventures, BlackFin Capital Partners, Partech Partners and RAISE Ventures also participated.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
    •

    November 2018 Commentary

    Driverless, Networked Vehicles on the Rise, French Liability Regulations Lag Behind

    • 12 avril 2018
      Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
    • 7 janvier 2016
      Le private equity : quelles opportunités pour 2016 ?

    Antes de enviar, por favor observe que:

    a Informação contida neste website (www.jonesday.com) destina-se a uso geral e não pode ser considerada como assessoria jurídica. O envio deste e-mail não tem por finalidade criar e seu recebimento não constitui uma relação cliente-advogado. Quaisquer conteúdos enviados para profissionais do Jones Day não são considerados confidenciais ou privilegiados a menos que sejamos seu representante legal. Ao enviar esta mensagem, você confirma que leu e concorda com este aviso.